US Broker Ratings

AtriCure, Inc. (ATRC) Stock Analysis: Evaluating a 52.52% Potential Upside in the Healthcare Sector

AtriCure, Inc. (NASDAQ: ATRC), a key player in the healthcare sector’s medical instruments and supplies industry, has been an intriguing focus for investors looking for growth potential. With a market..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Navigating Challenges with Innovative Bioelectric Solutions

Pulse Biosciences, Inc. (NASDAQ: PLSE) is a healthcare company at the forefront of bioelectric medicine, with a focus on developing advanced medical instruments and supplies. Headquartered in Miami, Florida, Pulse..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a Potential 23.76% Upside in Biotech

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotechnology company, is garnering attention in the healthcare sector, particularly for its innovative approaches to treating autoimmune diseases. With a market capitalization of..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 233% Upside Potential in Cancer Immunotherapy

Janux Therapeutics, Inc. (NASDAQ: JANX) is making waves in the biotechnology sector with its innovative approach to cancer treatment. Based in San Diego, California, this clinical-stage biopharmaceutical company leverages its..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Unveiling a 141% Potential Upside for Investors

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a dynamic player in the biotechnology sector, is capturing attention with its robust pipeline and significant growth potential. Headquartered in Altrincham, United Kingdom, Centessa is..

Certara, Inc. (CERT) Stock Analysis: Healthcare Innovator with 38% Potential Upside

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, specializes in health information services. The company commands a market capitalization of $1.85 billion and is recognized for its..

Agios Pharmaceuticals (AGIO) Stock Analysis: Examining a Potential 75.93% Upside in Biotechnology

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, has attracted significant attention from investors, particularly due to its potential upside of 75.93%. With a market capitalization..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Uncovering a 299% Potential Upside in Biotech

For investors seeking opportunities in the healthcare sector, particularly in the biotechnology industry, Dyne Therapeutics, Inc. (NASDAQ: DYN) presents an intriguing proposition. With a market capitalization of $1.33 billion, Dyne..

Amneal Pharmaceuticals (AMRX) Stock Analysis: Unpacking a 62.94% Potential Upside for Investors

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, is capturing investor attention with a notable potential upside of 62.94%. As a global biopharmaceutical company, Amneal develops..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring an 18% Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) has carved a niche in the specialized healthcare industry, focusing on non-opioid pain management solutions. With a market capitalization of $1.19 billion, this Tampa, Florida-based..

Innoviva, Inc. (INVA) Stock Analysis: 189.93% Potential Upside Sparks Investor Interest

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the healthcare sector, captivates investor attention with its impressive potential upside of nearly 190%. With a market capitalization of $1.19 billion, Innoviva..

ANI Pharmaceuticals (ANIP) Stock Analysis: Robust Revenue Growth and 40% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $1.25 billion, this U.S.-based biopharmaceutical..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring the 26% Potential Upside and Analyst Ratings

Investors looking for opportunities in the healthcare sector may find Pediatrix Medical Group, Inc. (NYSE: MD) an intriguing prospect, especially given its significant potential upside and solid analyst ratings. This..

Evotec SE (EVO) Stock Analysis: Unpacking a 36.61% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may find Evotec SE (EVO) an intriguing proposition, especially given its significant 36.61% potential upside. Headquartered in Hamburg, Germany, Evotec operates within..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring Its 222.59% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA), a promising player in the biotechnology sector, has caught the attention of investors with its substantial potential upside of 222.59%. Headquartered in Brisbane, California, this..

Sotera Health Company (SHC) Stock Analysis: Unpacking a 24.53% Potential Upside

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector as a diagnostic and research entity with a significant market capitalization of $3.45 billion. Headquartered in Broadview Heights, Ohio,..

Astrana Health Inc. (ASTH) Stock Analysis: Potential 106% Upside Captivates Investors

Astrana Health Inc. (ASTH), a key player in the healthcare sector, has caught the attention of investors with its remarkable growth prospects and significant potential upside. Despite a challenging year..

Mesoblast Limited (MESO): A Bold 148.85% Upside Potential Amidst Biotech Challenges

Mesoblast Limited (NASDAQ: MESO), the Melbourne-based biotechnology company, is a compelling entity for investors in the healthcare sector. Known for its pioneering work in regenerative medicine, Mesoblast is actively advancing..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 59% Potential Upside

Investors in Bausch Health Companies Inc. (NYSE: BHC) might find themselves at a crossroads, with the company offering a potentially lucrative upside of 59.18%. This Canadian healthcare giant, known for..

Teladoc Health, Inc. (TDOC) Investor Outlook: Examining a 32.55% Potential Upside Amidst a Challenging Market

Teladoc Health, Inc. (NYSE: TDOC), a leading player in the virtual healthcare sector, presents a fascinating case for investors with its significant potential upside of 32.55% despite the challenges it..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds